Author:
Ceriello Antonio,Giugliano Dario,Quatraro Antonio,Stante Aldo,Russo Patrizia Dello,Torella Roberto
Publisher
Springer Science and Business Media LLC
Subject
Endocrinology,General Medicine,Endocrinology, Diabetes and Metabolism,Internal Medicine,Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine
Reference19 articles.
1. Abildgaard U., Lie M., Odegard O. R.: Antithrombin III (heparin co-factor) assay with a ‘new’ chromogenic substrates (S-2238 and Chromozym TH) — Thrombos. Res.11, 549, 1977.
2. Banerjee R. N., Sahni A. L., Kumar U., Arya M.: Antithrombin III deficiency in maturity onset diabetes mellitus and atherosclerosis — Thrombos. Diathes. Haemorrh. (Stuttg.)31, 339, 1974.
3. Brownlee M.: α2-macroglobulin and reduced basement membrane degradation in diabetes — Lanceti, 779, 1976.
4. Brownlee M., Vlassara H., Cerami A.: Inhibition of heparin-catalyzed human antithrombin III activity by nonenzymatic glycosylation. Possible role in fibrin deposition in diabetes — Diabetes33, 532, 1984.
5. Ceriello A., Dello Russo P., Zuccotti C., Florio A., Nazzaro S., Pietrantuono C., Rosato G. B.: Decreased antithrombin III activity in diabetes may be due to non-enzymatic glycosylation. A preliminary report — Thrombos. Haemostas.50, 633, 1983.
Cited by
15 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献